ESC 2023 Update: Dapagliflozin fails to improve diuretic efficiency in acute heart failure: DICTATE-AHF trial Dr. Kamal Kant Kohli31 Aug 2023 8:30 AM ISTUSA: Dapagliflozin can be safely started upon hospital admission to rapidly optimise guideline-directed medical therapy (GDMT) among hospitalized...
ESC 2023 Reaffirms CV Safety of Sulphonylureas Agents Dr. Prem Aggarwal30 Aug 2023 11:30 AM ISTThe European Society of Cardiology (ESC) has released new guidelines for managing cardiovascular disease among patients with diabetes, simplifying...
Anticoagulation with edoxaban fails in patients with atrial high-rate episodes Dr. Kamal Kant Kohli30 Aug 2023 10:30 AM ISTGermany: Anticoagulation with edoxaban fails to significantly reduce the incidence of a composite of stroke, cardiovascular death, or systemic...
Mavacamten provides sustained improvement of HOCM symptoms even beyond 1 year: VALOR-HCM trial dr. Abhimanyu Uppal30 Aug 2023 9:30 AM ISTThe first drug in class of cardiac myosin inhibitors , mavacamten, received US FDA approval in 2022 following results of the EXPLORER-HCM trial. At...
Intraoperative or postoperative hydroxocobalamin, which is better for patients receiving cardiopulmonary bypass? Dr. Kamal Kant Kohli29 Aug 2023 8:00 PM ISTUSA: A recent study observed similar vasopressor-free days after cardiopulmonary bypass (CPB) in patients who received intraoperative versus...
Inorganic nitrate reduces contrast-induced nephropathy among patients undergoing angiography Dr. Kamal Kant Kohli29 Aug 2023 8:00 PM ISTUK: Inorganic nitrate improves the safety of coronary angiography for patients at risk of renal injury, results from the NITRATE-CIN trial have...
ESC 2023 Update: 12 months of anticoagulation improves outcomes in cancer patients with minor blood clots Dr. Kamal Kant Kohli29 Aug 2023 11:45 AM ISTTwelve months of edoxaban is superior to three months for the reduction of thrombotic events in patients with cancer and distal deep vein thrombosis ...
Flecainide may help achieve sinus rhythm in young rheumatic AF patients undergoing MVR Jacinthlyn Sylvia29 Aug 2023 10:00 AM ISTA recent study found that oral flecainide, a medication used to treat certain heart rhythm disorders, could be a valuable option for patients who...
ESC 2023 Update: Traditional Chinese medicine qiliqiangxin shows meaningful clinical benefits in patients with HF Dr. Kamal Kant Kohli29 Aug 2023 9:45 AM ISTChina: A recent study has supported the role of the traditional Chinese medicine qiliqiangxin as an adjunct therapy for treating heart failure. The...
Researchers develop new tool to reduce stroke risk Isra Zaman29 Aug 2023 9:30 AM ISTResearchers at the University of East Anglia have developed a new way of identifying patients at risk of an irregular heartbeat, known as ‘atrial...
Individuals experience sex-specific symptoms before impending cardiac arrest: Study Isra Zaman29 Aug 2023 9:15 AM ISTInvestigators from the Smidt Heart Institute at Cedars-Sinai are one step closer to helping individuals catch a sudden cardiac arrest before it...
ESC 2023 Update: Presence of three or more unhealthy traits tied to earlier heart attack and stroke in middle-aged adults Dr. Kamal Kant Kohli29 Aug 2023 9:00 AM ISTSweden: People in their 40s and 50s having three or more unhealthy traits including high blood pressure, waist circumference, glucose, and cholesterol...
